How Does Covetrus Company Work?

Covetrus Bundle

Get Bundle
Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10

TOTAL:

How Does Covetrus Operate?

Covetrus is a global animal health technology and services company that significantly impacts veterinary practices. Its focus is on integrating technology and services to support clinics, as seen with the upcoming Covetrus Platform™ unveiling before VMX 2025.

How Does Covetrus Company Work?

Serving over 100,000 veterinary practices globally, the company offers a wide array of solutions. These include practice management software, supply chain services for veterinary products, and advanced prescription management tools.

How does Covetrus work? It operates by providing a comprehensive technology and service ecosystem for veterinary professionals. This includes practice management software, supply chain services for veterinary products, and advanced prescription management tools, aiming to streamline operations and enhance patient care.

The company's strategic expansions, such as a new distribution center in May 2024 and an expanded pharmaceutical compounding facility in December 2024, underscore its commitment to growth and operational excellence. The global animal digital health market is projected to reach US$46.35 billion by 2034, growing at a CAGR of 21% from 2025, indicating a strong market for its services. For a deeper understanding of its market positioning, consider a Covetrus PESTEL Analysis.

What Are the Key Operations Driving Covetrus’s Success?

The Covetrus company operations are centered around providing an integrated platform of technology, products, and services to veterinary practices. This approach aims to streamline operations, enhance patient care, and address industry challenges like rising costs and staffing shortages. Understanding how Covetrus works reveals a business model focused on creating a connected ecosystem for animal health professionals.

Icon Integrated Technology Solutions

Covetrus offers a suite of practice management software, including Covetrus Pulse, Avimark, Impromed, RxWorks, and VisionVPM. These solutions are designed to optimize veterinary workflows and provide cloud-based capabilities for improved productivity.

Icon Comprehensive Supply Chain Services

The company provides access to over 22,000 products, including pharmaceuticals, equipment, and clinic supplies, often at competitive prices. This extensive offering supports veterinary inventory management and ensures practices have the necessary resources.

Icon Streamlined Prescription Management

Tools like vRxPro simplify the prescription process for veterinarians and offer convenient online pharmacy services with home delivery. This enhances client compliance and loyalty, a key aspect of Covetrus's value proposition.

Icon Holistic 'VetSuite' Approach

Covetrus bundles technology, products, and services into a connected care experience, known as VetSuite. This integrated model helps practices achieve workflow efficiencies and potential cost savings, estimated up to $14,000 annually.

Covetrus's business model is built on creating a unified platform that supports veterinary practices across various operational aspects. By integrating practice management software with a robust supply chain and efficient prescription services, the company empowers veterinarians to enhance both clinical and financial outcomes. This comprehensive approach, exemplified by their VetSuite offerings, allows veterinary professionals to dedicate more time to patient care. The company's strategic partnerships, such as those with National Veterinary Associates and Vetcor, further solidify its market position and distribution capabilities. Understanding the Competitors Landscape of Covetrus highlights the company's significant role in the animal health technology sector. The opening of a new distribution center in May 2024 underscores their commitment to efficient logistics and supply chain operations.

Icon

Key Benefits for Veterinary Practices

Covetrus's integrated solutions provide tangible benefits to veterinary clinics by improving efficiency and reducing administrative burdens. This allows practices to focus more on patient care and overall business performance.

  • Enhanced workflow efficiency through integrated software.
  • Reduced administrative tasks and operational costs.
  • Access to a wide range of competitively priced products.
  • Improved client loyalty and prescription compliance via online pharmacy services.

Covetrus SWOT Analysis

  • Complete SWOT Breakdown
  • Fully Customizable
  • Editable in Excel & Word
  • Professional Formatting
  • Investor-Ready Format
Get Related Template

How Does Covetrus Make Money?

As a privately held entity since October 2022, specific financial breakdowns for Covetrus's revenue streams are not publicly detailed. However, the company's comprehensive offerings indicate several primary income sources, reflecting its extensive operations in the animal health sector.

Icon

Supply Chain Services

A significant portion of Covetrus's revenue is generated through its supply chain services. This involves the distribution of animal health consumable goods, pharmaceuticals, and equipment to a vast network of veterinary customers.

Icon

Software Subscriptions and Licensing

Revenue is also derived from subscription and licensing fees for its practice management software solutions. These platforms are essential for veterinary practices to manage daily operations and patient data.

Icon

Prescription Management

The company monetizes its services through prescription management, including its online pharmacy and compounding services. This stream includes revenue from product sales and associated service fees.

Icon

'VetSuite' Network

Covetrus employs innovative strategies like the 'VetSuite' network. This model offers practices collective buying power, leading to cost savings on essential medications and supplies.

Icon

Strategic Partnerships

Partnerships with manufacturers and large veterinary networks are also integral to its monetization strategy. These collaborations leverage volume and integrated solutions to drive revenue.

Icon

Historical Revenue Performance

Prior to its privatization, in Q1 2022, the company reported revenues of $1.15 billion. This figure highlights the scale of its operations before becoming a private entity.

The Covetrus business model is designed to support veterinary practices by providing a comprehensive suite of products and services. This approach aims to enhance operational efficiency and profitability for its clients, contributing to its overall market position in animal health. Understanding Mission, Vision & Core Values of Covetrus provides further context on how these revenue streams align with the company's strategic objectives.

Covetrus PESTLE Analysis

  • Covers All 6 PESTLE Categories
  • No Research Needed – Save Hours of Work
  • Built by Experts, Trusted by Consultants
  • Instant Download, Ready to Use
  • 100% Editable, Fully Customizable
Get Related Template

Which Strategic Decisions Have Shaped Covetrus’s Business Model?

The journey of the Covetrus company has been defined by significant milestones and strategic shifts, establishing its presence in the animal health sector. Formed in 2019 through a substantial merger, the company later transitioned to private ownership in October 2022 for approximately $4 billion.

Icon Key Formation and Ownership Transition

Covetrus was established in 2019 by merging Henry Schein's animal health business with Vets First Choice. A major strategic move occurred in October 2022 when the company was acquired by Clayton, Dubilier & Rice and TPG Inc., moving it to private ownership for about $4 billion.

Icon Operational Enhancements and Technology Innovation

To support increasing demand, Covetrus opened a new distribution center in May 2024 and expanded its pharmaceutical compounding facility in December 2024. The company also launched vRxPro™ for prescription management in March 2024 and announced AI-powered features for its platform in January 2025.

Icon Navigating Regulatory Challenges

The company faced regulatory scrutiny, including a May 2024 guilty plea and over $23 million in fines for shipping misbranded veterinary drugs. Additionally, in October 2024, Covetrus settled allegations for $1.125 million related to opioid order oversight and recordkeeping.

Icon Competitive Strengths and Partnerships

Covetrus's competitive edge lies in its integrated 'Covetrus Platform' and 'VetSuite' network, offering comprehensive technology and services. Its extensive catalog of over 22,000 items and renewed partnerships with major veterinary groups like NVA and Vetcor in 2024 and 2023 respectively, enhance its market presence.

Icon

Covetrus Business Model and Market Position

The Covetrus business model focuses on providing integrated technology, products, and services to streamline operations and improve profitability for veterinary practices. This approach, combined with continuous adaptation to industry trends like AI integration, positions the company to address key challenges such as economic pressures and staffing shortages within the animal health sector.

  • The company's integrated platform aims to enhance veterinary practice efficiency.
  • Covetrus offers a broad product catalog, supporting diverse veterinary needs.
  • Strategic partnerships are crucial for expanding market reach and supply chain efficiency.
  • Adaptation to technological advancements, including AI, is a key differentiator.
  • The company's efforts to support veterinary practices address industry-wide challenges.
  • Understanding Brief History of Covetrus provides context for its current operations.

Covetrus Business Model Canvas

  • Complete 9-Block Business Model Canvas
  • Effortlessly Communicate Your Business Strategy
  • Investor-Ready BMC Format
  • 100% Editable and Customizable
  • Clear and Structured Layout
Get Related Template

How Is Covetrus Positioning Itself for Continued Success?

Covetrus operates as a significant global player in animal health technology and services, supporting over 100,000 veterinary practices. The company is a key contributor to the expanding animal digital health market, which is anticipated to reach approximately US$46.35 billion by 2034, growing at a compound annual growth rate (CAGR) of 21% from 2025. North America, a core market for Covetrus, represents a substantial 41.2% of this global market.

Icon Industry Position

Covetrus is recognized as a leading provider of integrated technology and services for veterinary practices worldwide. Its extensive reach across North America, Europe, and Asia-Pacific positions it as a vital partner in the animal health sector.

Icon Market Growth and Opportunity

The company operates within a rapidly growing animal digital health market, projected for significant expansion. This growth trajectory offers substantial opportunities for Covetrus to leverage its technological capabilities and service offerings.

Icon Key Risks and Challenges

Covetrus faces regulatory compliance challenges, as indicated by recent fines and settlements. Additionally, the veterinary industry is grappling with economic pressures and persistent staff shortages, impacting practice operations.

Icon Future Outlook and Strategy

The company's future strategy centers on enhancing its integrated solutions, including the Covetrus Platform™ and VetSuite™ network. Investment in AI capabilities and strategic partnerships aims to optimize veterinary workflows and client experiences.

Icon

Strategic Focus on Integrated Solutions

Covetrus is committed to advancing its technology platform to create a seamless connected care experience between veterinarians and pet parents. This includes integrating AI for workflow optimization and diagnostic support, as demonstrated by its collaboration with Zoetis Diagnostics.

  • Enhancing the Covetrus Platform™ and VetSuite™ network.
  • Incorporating AI capabilities to streamline veterinary workflows.
  • Reducing administrative burdens for veterinary professionals.
  • Improving diagnostic integration for better patient care.

The company's strategic initiatives are designed to empower veterinarians, improving both their clinical and financial outcomes. By focusing on technology adoption and a comprehensive service model, Covetrus aims to solidify its position as an essential partner for veterinary practices. This approach is crucial for capitalizing on the overall animal health market's projected growth of 10.46% CAGR from 2025 to 2030. Understanding the Marketing Strategy of Covetrus provides further insight into how the company supports veterinary practices and navigates the competitive landscape.

Covetrus Porter's Five Forces Analysis

  • Covers All 5 Competitive Forces in Detail
  • Structured for Consultants, Students, and Founders
  • 100% Editable in Microsoft Word & Excel
  • Instant Digital Download – Use Immediately
  • Compatible with Mac & PC – Fully Unlocked
Get Related Template

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.